Skip to main content
Fig. 8 | Journal of Experimental & Clinical Cancer Research

Fig. 8

From: Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors

Fig. 8

TNBC cell lines are sensitive to the combined treatment of SGI with MS275. a Dose response curve of breast epithelial/cancer cell lines to the treatment of SGI and MS275 by MTT assay. b The effect of SGI, MS275, or the combination treatment on the growth of breast epithelial/cancer cell lines. c Western blotting show inhibition of WNT and mutant p53 signaling pathways, and up-regulation of H3K27me3

Back to article page